ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Allergan
WAREHOUSE International Warehouse 2
SUBSTANCE Bimatoprost
Introducing LUMIGAN? 0.01%, the FDA-approved prescription eye drop specifically formulated to effectively reduce elevated intraocular pressure in individuals diagnosed with open-angle glaucoma or ocular hypertension. This powerful ophthalmic solution is your trusted ally in managing high eye pressure?a key risk factor for those living with glaucoma.
For patients struggling with open-angle glaucoma or ocular hypertension, LUMIGAN? 0.01% provides a reliable approach to maintaining eye health. The primary method for controlling high intraocular pressure involves the consistent use of this innovative prescription medication, ensuring your vision remains safeguarded.
Indication
LUMIGAN? (bimatoprost ophthalmic solution) 0.01% is specifically indicated for lowering high intraocular pressure (IOP) in individuals diagnosed with open-angle glaucoma or ocular hypertension.
Dosage and Administration
The recommended dosage is one drop in the affected eye(s) once daily in the evening. Adhering to this schedule is crucial, as exceeding the daily limit can diminish the effectiveness of LUMIGAN? (bimatoprost ophthalmic solution) 0.01% in lowering intraocular pressure. Patients can expect pressure reduction to commence approximately 4 hours after the initial dose, with optimal results typically observed between 8 to 12 hours later.